TFE3 and renal cell adenocarcinoma: The MIT category no longer exists. Two separate categories were made, namely the TFE3-rearranged and TFEB-altered RCC. Due to different clinical behaviour and prognosis, TFEB-altered RCC was again categorized into TFEB-rearranged and TFEB-amplified RCC.